SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-006206
Filing Date
2022-04-28
Accepted
2022-04-28 08:30:44
Documents
14
Period of Report
2022-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20220428x8k.htm   iXBRL 8-K 44573
2 EX-99.1 glyc-20220428xex99d1.htm EX-99.1 104263
3 GRAPHIC glyc-20220428xex99d1001.jpg GRAPHIC 7094
  Complete submission text file 0001558370-22-006206.txt   287415

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20220428.xsd EX-101.SCH 3399
5 EX-101.LAB glyc-20220428_lab.xml EX-101.LAB 15369
6 EX-101.PRE glyc-20220428_pre.xml EX-101.PRE 10388
8 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20220428x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 22862426
SIC: 2834 Pharmaceutical Preparations